Cargando…
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy
With the advent of checkpoint inhibition, immunotherapy has revolutionized the clinical management of several cancers, but has demonstrated limited efficacy in mammary carcinoma. Transcriptomic profiling of cancer samples defined distinct immunophenotypic categories characterized by different progno...
Autores principales: | Bedognetti, Davide, Roelands, Jessica, Decock, Julie, Wang, Ena, Hendrickx, Wouter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289005/ https://www.ncbi.nlm.nih.gov/pubmed/33525803 http://dx.doi.org/10.1042/ETLS20170142 |
Ejemplares similares
-
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018) -
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
por: Roelands, Jessica, et al.
Publicado: (2017) -
HLA-G: A New Immune Checkpoint in Cancer?
por: Krijgsman, Daniëlle, et al.
Publicado: (2020) -
Toward the identification of genetic determinants of breast cancer immune responsiveness
por: Simeone, Ines, et al.
Publicado: (2015) -
Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)